葡萄糖像-1调节尿路分泌在糖尿病病通过ENaC激活通过尿路分泌
Goh Kodama1, Kensei Taguchi2,3, Sakuya Ito1
1Division of Nephrology, Department of Medicine, Kurume University School of Medicine, 67, Asahi-machi, Kurume city, 830-0011, Fukuoka, Japan.
Scientific reports
|April 3, 2025
概括
结合linagliptin和empagliflozin,通过降低表皮质道水平,降低了糖尿病病患者的盐敏感性. 这种组合疗法在预防DKD患者损伤方面表现有前途.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DKD) 是末期病的主要原因之一.
- 与上皮质通道 (ENaC) 过度表达相关的盐敏感性升高是DKD的潜在危险因素.
- 了解减轻盐敏感性的机制对于DKD管理至关重要.
研究的目的:
- 调查林格利普丁 (LINA) 和恩帕格利弗洛辛 (EMPA) 联合治疗对DKD患者盐敏感性的影响.
- 探索这种组合对化Nedd4-2 (p-Nedd4-2) 和ENaC水平的影响.
- 阐明葡萄糖类-1 (GLP-1) 受体轴在调解这些效应中的作用.
主要方法:
- 使用了DKD大鼠和脱氧皮质/高盐处理的小鼠模型.
- 单独和组合使用LINA和EMPA.
- 研究对尿路分泌 (USE),p-Nedd4-2和ENaC水平的影响.
- 使用培养的远端管道进行了体外研究.
- 分析了用SGLT2抑制剂和DPP-4抑制剂治疗的DKD患者的数据.
主要成果:
- 林纳和EMPA的联合治疗,但不仅仅是EMPA,在DKD大鼠中降低了p-Nedd4-2和ENaC水平,增加了USE.
- 在高盐处理的小鼠中,LINA加EMPA显示出更大的脏保护作用.
- 通过GLP-1受体轴,LINA在体外抑制了高盐/葡萄糖诱导的p-Nedd4-2和ENaC的增加.
- 在SGLT2is和DPP4is上的DKD患者表现出更高的USE和更低的ENaC表达.
结论:
- 将LINA添加到EMPA中可以降低p-Nedd4-2和ENaC水平,这可能是通过GLP-1受体的激活.
- 这种组合可以改善盐敏感性,并有可能在DKD中保护脏.
- 研究结果表明,通过向盐敏感路径来管理DKD的新型治疗策略.
相关概念视频
Introduction to Urinary System
1.8K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
1.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics
417
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
417
Glucagon-like Receptor Agonists
276
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
276
Regulation of Sodium and Potassium
313
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
313
Antihypertensive Drugs: Action of Diuretics
590
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
590
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K


